Form D Explorer

Inspect source fieldsReport a record issue

Form D — Coeptis Therapeutics Holdings, Inc.

0001683168-25-005718 · filed Aug 7, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$5,000,000
Reported amount sold
$4,000,000
Minimum investment
$100,000
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Coeptis Therapeutics Holdings, Inc.
CIK
1759186
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2022
Address
105 BRADFORD ROAD
WEXFORD, Pennsylvania 15090
Phone
724-934-6467

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗